Options: Subsidiary The Choice Group acquires the remaining 66.7% of Choice Medical

Options Cassoulides Public Company Ltd would like to inform investors that its 100% subsidiary “The Choice Group” based in London signed an agreement with Mr. Brian Green for the acquisition of 66.7% of the share capital of Choice Medical Communications Ltd. Our subsidiary, The Choice Group, held to date 33.3% of the issued share capital of Choice Medical Communications Ltd.

The acquisition price has been set at UK£583,000 and the agreement has retrogressive effect from January 1, 2005.

Choice Medical Communications Ltd was established in 2001 by Mr. Brian Green. Its main activity is the provision of services to medical companies on medical communication and development of new pharmaceutical product issues.

The Company’s customer list includes Pfizer, GlaxoSmithKline, GE Healthcare, Biosciences and Abbott. The Company is acclaimed for their evidence based on medicine program “Prospect” in post operative pain procedure for a large number of operations.

The acquisition of the entire share capital of Choice Medical Communications Ltd falls within the strategic development program of the Medical Conference and Events, which is actively involved under the business name The Choice Group, aiming at strengthening the range of services that the sector offers to multinational healthcare and medical companies. The incorporation of Choice Medical Communications Ltd will expand its turnover in the sector and will contribute to the Group’s profits.

In 2004, the sales of Choice Medical Communications Ltd reached UK£2,000,000 and its net profits stood at UK£230,000.

Mr. Brian Green will be the Business Development Director.

The press release in the UK is as follows:

Press release

LONDON, November 3, 2005 The Choice Group, buys Choice Medical Communications, the UK based international medical communications agency.

The Choice Group, the global healthcare and medical society services group, today announced that it had acquired 100% of Choice Medical Communications, the UK based international medical communications agency.

To be called The Choice Group, the agency will reinforce and expand The Choice Group’s offering to blue chip healthcare and medical society clients from its offices in Hitchin. Choice Medical Communications will bring to the group eleven healthcare communications professionals and a client list that includes international accounts with Pfizer, GlaxoSmithKline, GE Healthcare Biosciences and Abbott.

The company has executed numerous successful programmes in anaesthesia, BPH and prostate cancer, haematology and oncology. Choice Medical Communications is acclaimed for their evidence based medicine programme PROSPECT in post operative pain procedure specific postoperative pain management. (www.postoppain.org).

In making the announcement Tim Ball, Managing Director of The Choice Group said, "Acquiring Choice Medical Communications is in line with our strategy of offering a comprehensive service offering to our clients. We are very excited about the opportunity Choice Medical Communications grants The Choice Group, as they have a great client base --many of whom we share --and will instantly make us more competitive in growing our existing business and securing new global accounts."

Brian Green, Founder and Managing Director of Choice Medical Communications, added "We are delighted and extremely excited about joining The Choice Group. Our mission is to satisfy our clients’ communication needs through a combination of strategic vision, healthcare experience, commitment to quality implementation and passion for client service. The Choice Group will help us increase our service offerings while creating further opportunities."

Brian Green will remain with The Choice Group becoming Business Development Director. Anne Pringle Davies becomes Managing Director Choice Medical Communications.

The Choice Group creates a single organisation with almost 70 employees with a turnover in excess of £15 million, which is poised for strategic growth by offering new, more powerful and creative products and services.

Source: The Choice Group Contact: Tim Ball Managing Director The Choice Group +44 1462 471 803 Brian Green Business Development Director The Choice Group +44 1462 471 822 Website: www.thechoicegroup.net.